Daily Chart

Pfizer Inc. (PFE) Financial News - Google, Pfizer, Vizio, Zynga, Apple, Sturgis, CBS: Intellectual Property

Pfizer Inc. (PFE)

Google, Pfizer, Vizio, Zynga, Apple, Sturgis, CBS: Intellectual Property

Quote: Pfizer Wins Viagra Patent-Infringement Case Against Teva Pfizer Inc. (PFE)Teva Pharmaceutical Industries Ltd. (TEVA) from marketing a generic version of the impotence drug Viagra until 2019. Virginia, ruled Aug. 12 against Petach Tikva, Israel-based Teva, which claimed patent 6,469,012 wasn’t valid and couldn’t be enforced. “Teva has not shown by clear and convincing evidence that the patent is invalid,” Smith said in a 110-page opinion. In addition, “there is utterly no evidence” to support Teva’s claim that that Pfizer intentionally withheld documents from the U.S. Patent and Trademark Office, Smith wrote. Viagra sales increased 5.5 percent in the first quarter to $479 million, Pfizer said in May. New York-based Pfizer, the world’s biggest drugmaker, posted net income of $8.26 billion last year on sales of $67.8 billion. “Protecting the intellectual property rights of our innovative core is critical,” Amy Schulman, Pfizer’s general counsel, said in a statement. “Friday’s court decision acknowledges Teva’s clear violation of our patent rights.” The ruling was “a surprise,” Bloomberg Industries analyst Asthika Goonewardene said in an interview. “The patent was a method-of-use patent, and usually these don’t hold up that well in court for small molecular drugs,” Goonewardene said. “The court’s decision to uphold this patent means other filers wanting to enter in 2012 are not likely to do so then.” Denise Bradley, a Teva spokeswoman, declined to comment on the ruling. The case is Pfizer v. Teva, 10-cv-128, U.S. District Court, Eastern District of Virginia (Norfolk). Renesas Patent Complaint Seeks to Bar U.S. Imports of Vizio TVs Renesas Electronics Corp. (6723), the world’s biggest maker of microcontrollers used in cars and appliances, filed patent- infringement complaints seeking to block Vizio Inc. televisions from the U.S. ...
Open whole article (external link)

Other Financial and Stock Market News concerning Pfizer Inc.

Pfizer Inc. Stock Summary

Pfizer Inc. engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. Its Pharmaceutical segment offers Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimer?s disease. It also provides Celebrex for arthritis pain, and inflammation and acute pain; Vfend for esophageal candidiasis and blood stream infections; Zyvox for bacterial infections; and Selzentry/Celsentri for adults infected with only CCR5-tropic HIV-1 detectable. In addition, this segment provides Viagra for erectile dysfunction; Detrol and Toviaz for overactive bladder; Camptosar for metastatic colorectal cancer; Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; and Genotropin for growth disorders. The company?s Animal Health segment offers parasiticides, anti-inflammatories, antibiotics, vaccines, antiemetics, and anti-obesity agents. It also provides Revolution/Stronghold for dogs and cats; Rimadyl for pain and inflammation associated with canine osteoarthritis and soft tissue orthopedic surgery; Clavamox/Synulox for skin and soft tissue infections; RespiSureOne/StellamuneOne to prevent pneumonia in swine; Bovi-Shield Gold for reproductive and respiratory protection; Dectomax, an injectable and pour-on formulations; Draxxin, an antibiotic for infections in cattle and swine; and Excede to treat infections in dairy cows, beef cattle, and swine. Pfizer Inc. also involves in contract manufacturing and bulk pharmaceutical chemicals businesses. It serves doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. The company was founded in 1849 and is headquartered in New York, New York.
Stocktweeting is not a financial advisor, and in no way recommends the purchase of any stock or advise on the suitability of any trade or investment.
Stock trading and investing can cause loss of capital, and you should always consult with a professional financial advisor before trading or investing.

This website is a service of the HagensMedia ad network. For advertising please visit http://www.hagensmedia.com - Copyright 2011-2012.